<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>23</Volume><Issue>3</Issue><PubDate PubStatus="epublish"><Year>2018</Year><Month>03</Month><Day>19</Day></PubDate></Journal><title locale="en_US">Correlation between Vitamin D3 level and extrahepatic manifestation in chronic hepatitis type?C virus patients</title><FirstPage>10768</FirstPage><LastPage>10768</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>18</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Background: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Chronic hepatitis type?C virus (HCV) infection is one of the most common worldwide viral disorders, which leads to various clinical complications as well as extrahepatic manifestations. Furthermore, Vitamin D3 has also been reported to have relationship with the mentioned  complications. Te aim is to evaluate the correlation between Vitamin D3 level and extrahepatic manifestation in chronic HCV patients. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Tis cross?sectional study has been carried out on 90 patients&lt;br /&gt;with chronic hepatitis C. Te level of Vitamin D3 was assessed in plasma of 90 patients with chronic HCV. Genotyping was done and clinical and sign and symptoms of recruited patients were gathered. Extrahepatic  anifestations were evaluated and the correlation of blood, hepatic, and immunological factors and the level of Vitamin D3 were assessed. &lt;/span&gt;&lt;span class="fontstyle0"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle2"&gt;Most of our patients were male (92% vs. 8%). Twenty?nine percent had the insufcient amount of Vitamin D3 (21–30 ng/ml), and the remains had the&lt;br /&gt;Vitamin D3 level between 13–20 ng/ml. Furthermore, our assessment demonstrated that defciency of Vitamin D3 was associated with the extrahepatic manifestations such as purpura (odds radio [OR] [95% confdence interval (CI) 95%] = 8.80 [1.74–44.47], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.004), vasculitis (OR [95% CI] = 11.70 [3.01–45.41], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001), arthralgia (OR [95% CI] = 20.26 [4.21–97.47], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;&amp;lt; 0.001), myalgia (OR [95% CI] = 4.00  [1.01–17.27], &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.048), and glomerulonephritis (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle2"&gt;= 0.021). &lt;/span&gt;&lt;span class="fontstyle0"&gt;Conclusions: &lt;/span&gt;&lt;span class="fontstyle2"&gt;According to our results, the extrahepatic manifestation in the patients with sufcient levels of Vitamin D3 would be less possible. In fact, it could be stated that defciency in the Vitamin D3 can have a signifcant  relationship with these manifestations.&lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10768</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10768/5608</pdf_url></Article></Articles>
